KCTD1 and cancer: We induced KILR and KCTD1-5 expression in one normal (MCF10A) and two cancer (MCF7s and Hs578T) breast cell lines, by targeting CRISPRa to their shared promoter (Supplementary Fig. 3a) and observed significantly suppressed cell proliferation in all three cell lines (Fig. 2a).